Pt levels following the infusion of daily low-dose cisplatin
Hayase, R.; Yamamoto, J.; Yamamoto, M.; Kodama, J.; Tamada, T.; Kudoh, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 565-568
1995
ISSN/ISBN: 0385-0684 PMID: 7887651 Document Number: 440156
Document emailed within 1 workday
Related Documents
Sasaki, K.; Hirata, K.; Denno, R.; Oikawa, I.; Mukaiya, M.; Hiraike, N.; Yagihashi, A.; Takasaka, H.; Katsuramaki, T.; Yamashiro, K.; Yamamitsu, S.; Shirasaka, T. 1997: Combination chemotherapy of continuous infusion 5-fluorouracil and daily low-dose cisplatin in advanced gastrointestinal and lung adenocarcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(8): 959-964Nakano, K.; Yamamoto, M.; Iwamoto, H.; Hiramoto, T. 2003: Daily low-dose cisplatin plus concurrent high-dose thoracic radiotherapy in elderly patients with locally advanced unresectable non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(9): 1283-1287
Hato, N.; Yumoto, E.; Hyodo, M.; Hinohira, Y.; Kawamura, T.; Fujii, T. 1998: Radiotherapy combined with daily administration of low-dose cisplatin for squamous cell carcinomas of the head and neck Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(10): 1533-1537
Fujii, S.; Hamamoto, Y.; Sugai, Y. 1993: Concurrent daily low-dose cisplatin combined with chest irradiation in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(10): 1397-1399
Soukop, M. 1990: A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S15-S19
Seike, M.; Andoh, M.; Hasegawa, K.; Sakonji, M.; Tsuboi, E. 1998: Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(10): 1539-1542
Itamoto, T.; Asahara, T.; Kohashi, T.; Katayama, S.; Fukuda, S.; Nakatani, T.; Fukuda, T.; Yano, M.; Nakahara, H.; Katayama, K.; Haruta, N.; Dohi, K. 1999: Hepatic arterial infusion of low-dose cisplatin, 5-fluorouracil for hepatocellular carcinoma with tumor thrombi in the portal vein Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(12): 1832-1835
Niiya, F.; Ikeda, S.; Nagata, S.; Iwamoto, M.; Shirouzu, K. 2001: A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(3): 391-394
Boven, E.; Tierie, A.H.; Stam, J.; Pinedo, H.M. 1988: Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: results of a phase Ii trial Seminars in Oncology 15(6 Suppl 7: 18-19
Asano, M.; Mori, T.; Takahashi, K.; Yasuno, M. 1997: Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(1): 55-60
De Gaudemaris, R.; Battistella, P.; Siche, J.P.; Debru, J.L.; Blatier, J.F.; Mallion, J.M. 1986: Comparative study of the efficacy of captopril at a single daily dose of 100 mg and at a twice daily dose of 50 mg by measuring ambulatory pressure over 24 hours Postgraduate Medical Journal 62 Suppl. 1: 97-100
Barker, G.H.; Wiltshaw, E. 1981: Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma Lancet 1(8223): 747-750
Wasmuth, J.-C.; la Porte, C.J.L.; Schneider, K.; Burger, D.M.; Rockstroh, J.K. 2004: Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR) Antiviral Therapy 9(2): 213-220
Jing, Q.Y.; Liu, Z.D.; Yang, Y.Q.; Shan, C.Y.; Wang, D.B.; Jiang, Y.M. 1982: Dynamic observations of blood sugar and insulin levels with low-dose insulin infusion Chinese Medical Journal 95(12): 915-920
Fichtinger-Schepman, A.M.; Vendrik, C.P.; van Dijk-Knijnenburg, W.C.; de Jong, W.H.; van der Minnen, A.C.; Claessen, A.M.; van der Velde-Visser, S.D.; de Groot, G.; Wubs, K.L.; Steerenberg, P.A. 1989: Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma Cancer Research 49(11): 2862-2867
Bhatia, A.; Tripathi, K.D.; Sharma, M. 2003: Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy Indian Journal of Medical Research 118: 33-41
Hua, X.-m.; Ren, X.-w.; Liu, F.-l.; Liu, Y.; Zhang, C.-j.; Li, Z.-j.; Xu, L.; Liu, J.-y.; Liu, Y.-g. 2004: Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC Zhonghua Zhong Liu Za Zhi 26(10): 621-625
Wasserman, M.J.; Weber, D.A.; Guthrie, J.A.; Bykerk, V.P.; Lee, P.; Keystone, E.C. 2004: Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number Journal of Rheumatology 31(10): 1912-1917
Bozzino, J.M.; Prasad, V.; Koriech, O.M. 1981: Avoidance of renal toxicity by 24-hour infusion of cisplatin Cancer Treatment Reports 65(3-4): 351-352
Furue, H. 2001: DDP-H, new formulation of cisplatin for hepatic artery infusion therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 670-673